Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1965 13
1966 15
1967 18
1968 21
1969 28
1970 28
1971 31
1972 20
1973 23
1974 24
1975 17
1976 16
1977 21
1978 22
1979 20
1980 20
1981 14
1982 11
1983 20
1984 20
1985 17
1986 13
1987 20
1988 21
1989 30
1990 26
1991 31
1992 29
1993 36
1994 43
1995 46
1996 51
1997 46
1998 38
1999 46
2000 40
2001 41
2002 60
2003 69
2004 66
2005 72
2006 81
2007 86
2008 81
2009 68
2010 97
2011 108
2012 116
2013 112
2014 109
2015 138
2016 139
2017 122
2018 120
2019 108
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

2,544 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.
Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G. Richeldi L, et al. Eur Respir Rev. 2018 Dec 21;27(150):180074. doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578333 Free article. Review.
Personalized medicine in interstitial lung diseases.
Spagnolo P, Oldham JM, Jones MG, Lee JS. Spagnolo P, et al. Curr Opin Pulm Med. 2017 May;23(3):231-236. doi: 10.1097/MCP.0000000000000370. Curr Opin Pulm Med. 2017. PMID: 28198728 Free article. Review.
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.
Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM. Volkmann ER, et al. Arthritis Rheumatol. 2017 Jul;69(7):1451-1460. doi: 10.1002/art.40114. Epub 2017 May 23. Arthritis Rheumatol. 2017. PMID: 28376288 Free PMC article.
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™).
Distler O, Brown KK, Distler JHW, Assassi S, Maher TM, Cottin V, Varga J, Coeck C, Gahlemann M, Sauter W, Schmidt H, Highland KB; SENSCIS™ trial investigators. Distler O, et al. Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):75-81. Epub 2017 Jun 29. Clin Exp Rheumatol. 2017. PMID: 28664834 Free article. Clinical Trial.
Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management?
Tomassetti S, Ryu JH, Piciucchi S, Chilosi M, Poletti V. Tomassetti S, et al. Semin Respir Crit Care Med. 2016 Jun;37(3):378-94. doi: 10.1055/s-0036-1583176. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231862 Review.
Pharmacogenetics and interstitial lung disease.
Oldham JM, Noth I, Martinez FJ. Oldham JM, et al. Curr Opin Pulm Med. 2016 Sep;22(5):456-65. doi: 10.1097/MCP.0000000000000289. Curr Opin Pulm Med. 2016. PMID: 27253772 Free PMC article. Review.
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
Adler S, Huscher D, Siegert E, Allanore Y, Czirják L, DelGaldo F, Denton CP, Distler O, Frerix M, Matucci-Cerinic M, Mueller-Ladner U, Tarner IH, Valentini G, Walker UA, Villiger PM, Riemekasten G; EUSTAR co-workers on behalf of the DeSScipher project research group within the EUSTAR network. Adler S, et al. Arthritis Res Ther. 2018 Jan 30;20(1):17. doi: 10.1186/s13075-018-1517-z. Arthritis Res Ther. 2018. PMID: 29382380 Free PMC article.
2,544 results
Jump to page
Feedback